Skip to main content

Table 1 The clinical characteristics of 136 patients with advanced gastric cancer

From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer

Characteristic

Total

n = 136 (%)

NLR

PLR

Mean ± SEM

P value

Mean ± SEM

P value

Gender

  

0.876

 

0.115

 Male

82 (60.3%)

3.36 ± 0.30

 

191.66 ± 11.84

 

 Female

54 (39.7%)

3.43 ± 0.37

 

222.64 ± 16.00

 

Age

  

0.446

 

0.966

 ≤55 years

74 (54.4%)

3.55 ± 0.37

 

204.34 ± 12.45

 

 >55 years

62 (45.6%)

3.20 ± 0.24

 

203.51 ± 15.06

 

Differentiation

  

0.144

 

0.169

 Poor

90 (66.2%)

3.59 ± 0.32

 

213.43 ± 10.70

 

 Moderate/Well

46 (33.8%)

2.99 ± 0.25

 

185.44 ± 19.07

 

Chemotherapy regimen

  

0.158

 

0.964

 FOLFOX

40 (29.4%)

3.77 ± 0.52

 

209.31 ± 16.29

 

 CapeOX

26 (19.1%)

3.94 ± 0.70

 

200.37 ± 26.76

 

 TP

21 (15.4%)

3.58 ± 0.42

 

210.15 ± 22.98

 

 Others

49 (36.1%)

2.71 ± 0.22

 

198.85 ± 15.84